EUVIMEDEUVIMED entdecken
Crossref

VALUE OF FECAL CALPROTECTIN AS A NON-INVASIVE MARKER DIFFERENTIATING ORGANIC FROM FUNCTIONAL BOWEL DISEASES

Yasser Sheta, Ihab Salem, Waleed Ismail, Abeer Hafez

Zagazig University Medical Journal · 01.07.2013 · 19 (4) · 1-6

DOI: 10.21608/zumj.2013.4262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zagazig University Medical Journal, online erschienen am 01.07.2013. Verfasst von Yasser Sheta und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bowel diseases are very common, most of them are functional not organic in nature but clinicians suffer a lot in differentiating between the two categories especially the management is completely different. The symptoms of functional bowel diseases can be very similar to organic inflammatory bowel diseases like ulcerative colitis. In many cases the definitive diagnosis needs invasive procedures including lower colonoscopy and biopsy for histopathological documentation. Aim of the work: To evaluate the clinical value of fecal calprotectin as a non invasive marker differentiating organic from functional bowel diseases in correlation with endoscopic and histopathological examinations. Subjects and methods: The study included 40 patients, selected to represent 2 groups: group (I) included 20 patients with ulcerative colitis (UC) proved by colonoscopy and histopathology who further subdivided into sub-groups according to activity and site of involvement; and group (II) included 20 patients who had symptoms suggestive of irritable bowel syndrome (IBS) and in whom colonoscopy was found to be normal served as control. All participants were subjected to thorough history taking, physical examination and routine laboratory investigations. Calprotectin in feces was measured using the enzyme-linked immunosorbent assay (ELISA).

Results

Fecal calprotectin concentration in the patients with UC was significantly higher than in patients with IBS (Mean values ± SD; 201.7 ± 46.7 μg/g vs, 22.3 ± 10.1 μg/g, P < 0.01). A significant difference was also found in the patients with active UC in comparison to UC patients without sign of activity (Mean values ± SD; 220.2 ± 31.1 μg/g vs, 167.3 ± 23.9 μg/g, P

Zitieren

APA

Sheta, Y., Salem, I., Ismail, W., & Hafez, A. (2013). VALUE OF FECAL CALPROTECTIN AS A NON-INVASIVE MARKER DIFFERENTIATING ORGANIC FROM FUNCTIONAL BOWEL DISEASES. Zagazig University Medical Journal, 19(4), 1-6. https://doi.org/10.21608/zumj.2013.4262

Vancouver

Sheta Y, Salem I, Ismail W, Hafez A. VALUE OF FECAL CALPROTECTIN AS A NON-INVASIVE MARKER DIFFERENTIATING ORGANIC FROM FUNCTIONAL BOWEL DISEASES. Zagazig University Medical Journal. 2013;19(4):1-6. doi:10.21608/zumj.2013.4262

BibTeX
@article{Sheta2013,
  author = {Sheta, Yasser and Salem, Ihab and Ismail, Waleed and Hafez, Abeer},
  title = {VALUE OF FECAL CALPROTECTIN AS A NON-INVASIVE MARKER DIFFERENTIATING ORGANIC FROM FUNCTIONAL BOWEL DISEASES},
  journal = {Zagazig University Medical Journal},
  year = {2013},
  volume = {19},
  number = {4},
  pages = {1--6},
  doi = {10.21608/zumj.2013.4262}
}
Kostenlos starten →